Can psilocybin-assisted therapy provide long-term remission from major depression? A long-term study has shown that 67% of participants with major depression were still in remission five years after psilocybin-assisted therapy. This article will explore the details of this study, the implications for long-term depression treatment,...
This article examines the latest national survey data to understand the trends and demographics of psychedelic use among young adults in the United States, exploring who is using these substances and why their use is on the rise. Synopsis Recent data from national surveys reveals...
This article explores the growing body of scientific evidence demonstrating the effectiveness of esketamine, particularly the nasal spray formulation, in treating anhedonia—a core symptom of depression characterized by an inability to feel pleasure. Synopsis For individuals struggling with treatment-resistant depression, anhedonia can be one of...
This article explores the emerging scientific evidence that connects psilocybin use to changes in social behavior and the gut microbiome, and what these findings could mean for the future of mental health treatment. Synopsis Recent research is uncovering a surprising and complex relationship between psilocybin...